![Leon F. Richards](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Leon F. Richards
Plus aucun poste en cours
Profil
Leon F.
Richards served as Chief Accounting Officer & Controller at Baldwin Technology Co., Inc. from 2004 to 2012.
He then held the same position at Transgenomic, Inc. from 2014 to 2016.
Richards received his undergraduate degree from Iona College.
Anciens postes connus de Leon F. Richards
Sociétés | Poste | Fin |
---|---|---|
Transgenomic, Inc.
![]() Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | Comptroller/Controller/Auditor | 30/09/2016 |
Baldwin Technology Co., Inc.
![]() Baldwin Technology Co., Inc. Electronic Equipment/InstrumentsElectronic Technology Baldwin Technology Co., Inc. manufactures and supplies process automation equipment and related consumables for the packaging and printing industry. It offers consumables, fluid management, spray, surface cleaning, ultraviolet (UV) and IR systems, UV lamps, web applications, and web process control solutions. The company was founded by William Gegenheimer in 1918 and is headquartered in St. Louis, MO. | Comptroller/Controller/Auditor | - |
Formation de Leon F. Richards
Iona College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Baldwin Technology Co., Inc.
![]() Baldwin Technology Co., Inc. Electronic Equipment/InstrumentsElectronic Technology Baldwin Technology Co., Inc. manufactures and supplies process automation equipment and related consumables for the packaging and printing industry. It offers consumables, fluid management, spray, surface cleaning, ultraviolet (UV) and IR systems, UV lamps, web applications, and web process control solutions. The company was founded by William Gegenheimer in 1918 and is headquartered in St. Louis, MO. | Electronic Technology |
Transgenomic, Inc.
![]() Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | Health Technology |